In the five years since Philadelphia's first hormone-replacement therapy case went to trial, a jury has awarded punitive damages as high as $75 million, more than 1,000 cases have been tossed out of court and then revived on appeal, and HRT drugmaker Wyeth was bought by Pfizer.
May 20, 2011 at 12:00 AM
1 minute read
In the five years since Philadelphia’s first hormone-replacement therapy case went to trial, a jury has awarded punitive damages as high as $75 million, more than 1,000 cases have been tossed out of court and then revived on appeal, and HRT drugmaker Wyeth was bought by Pfizer.
Now, settlement is the name of the game in Philadelphia’s largest pharmaceutical litigation since the 10,000-strong diet drug litigation of the mid-2000s.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
The premier educational and networking event for employee benefits brokers and agents.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
